Pharming Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	145.31	54.94	61.74	207.34	191.92
Short-Term Investments	33.8	112.95	151.68	-	-
Cash & Short-Term Investments	179.1	167.89	213.42	207.34	191.92
Cash Growth	6.68%	-21.33%	2.93%	8.03%	-6.45%
Accounts Receivable	41.77	41.53	35.41	20.96	18.08
Other Receivables	6.67	8.64	7.21	4.37	9.52
Receivables	48.44	50.17	42.62	25.33	27.59
Inventory	64.9	55.72	56.76	42.33	27.31
Prepaid Expenses	6.26	4.65	3.54	2.29	2.39
Restricted Cash	0.76	-	-	0.21	0.23
Other Current Assets	0	-	-	-	-
Total Current Assets	299.47	278.44	316.34	277.5	249.44
Property, Plant & Equipment	23.97	24.13	33.47	39.15	33.17
Long-Term Investments	8.65	4.23	10.4	9.73	8.65
Goodwill	3.32	-	-	-	-
Other Intangible Assets	132.22	61.04	71.27	74.87	83.57
Long-Term Deferred Tax Assets	31.02	30.54	29.76	22.97	21.22
Long-Term Deferred Charges	-	-	-	0.25	0.27
Other Long-Term Assets	1.32	1.6	1.62	1.33	1.01
Total Assets	499.96	399.99	462.85	425.8	397.32
Accounts Payable	8.55	10.1	16.02	8.75	7.6
Accrued Expenses	91.31	53.22	50.27	43.61	33.34
Current Portion of Long-Term Debt	5.34	4.25	1.82	1.77	1.88
Current Portion of Leases	3.37	2.95	3.62	3.47	2.42
Current Income Taxes Payable	6.04	3.28	6.23	2.1	1.51
Other Current Liabilities	1.19	-	-	-	0.03
Total Current Liabilities	115.79	73.8	77.97	59.7	46.77
Long-Term Debt	92.72	78.15	136.6	131.62	139.01
Long-Term Leases	14.35	26.97	29.51	29.84	18.46
Other Long-Term Liabilities	-	-	-	-	0.17
Total Liabilities	222.86	178.92	244.07	221.16	204.4
Common Stock	8.01	7.77	7.67	7.51	7.43
Additional Paid-In Capital	513.26	488.99	478.43	462.3	455.25
Retained Earnings	-258	-287.92	-265.5	-265.17	-269.77
Comprehensive Income & Other	13.84	12.23	-1.82	-	-
Shareholders' Equity	277.1	221.06	218.78	204.64	192.92
Total Liabilities & Equity	499.96	399.99	462.85	425.8	397.32
Total Debt	115.78	112.31	171.55	166.69	161.76
Net Cash (Debt)	63.33	55.58	41.88	40.65	30.16
Net Cash Growth	13.94%	32.72%	3.03%	34.76%	-30.18%
Net Cash Per Share	0.08	0.08	0.06	0.06	0.04
Filing Date Shares Outstanding	701.68	683.93	673.44	656.35	648.75
Total Common Shares Outstanding	701.68	680.31	671.07	656.35	648.75
Working Capital	183.68	204.64	238.37	217.8	202.67
Book Value Per Share	0.39	0.32	0.33	0.31	0.30
Tangible Book Value	141.56	160.02	147.51	129.77	109.35
Tangible Book Value Per Share	0.20	0.24	0.22	0.20	0.17
Land	-	-	-	-	0.03
Machinery	10.57	9.3	9.66	8.28	14.84
Construction In Progress	-	0.15	0.18	0.01	0.62
Leasehold Improvements	6.4	5.43	5.55	5.28	5.71

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.